| Quality baseline 50 → 48 Poor |
| +16 | Public COA availability on product pages 3, 10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23 Current public product pages and sampled 2023-2026 COAs; full weight. Rubric range +15 to +20 for public COA portal. Awarded +16, not +20, because SuperSmart makes COAs highly accessible, but sampled COAs vary in depth and are not a uniform batch-lookup portal with consistent finished-product potency plus contaminants. · full weight |
| +4 | Heavy metal testing disclosed on sampled COAs 17, 19, 20 Sampled COAs dated 2024-2026 or current product-linked documents; full weight. Rubric range +3 to +6 for heavy metal testing disclosure. · full weight |
| +4 | Microbiological testing disclosed on sampled COAs 18, 19, 20, 21, 23 Sampled COAs dated 2023-2026 or current product-linked documents; full weight. Rubric range +3 to +6 for microbiological testing disclosure. · full weight |
| +3 | Ingredient identity / release testing appears in sampled COAs 17, 18, 19, 20, 21, 23 Current and recent sampled COAs; full weight. Rubric range +3 to +6 for ingredient identity testing. Awarded low end because identity methods are inconsistent across samples: some show FTIR or supplier assay, while others rely on ingredient-addition verification or batch certificates. · full weight |
| −25 | FDA warning letter 7 FDA warning letter dated January 21, 2026, inside last 2 years; 100% recency weight applied. Rubric range -25 to -35. Chose low end because the letter cited disease/drug claims rather than a cGMP manufacturing failure, contamination finding, or recall. · full weight |
| −4 | Sampled public COAs are a real transparency advantage, but they do not consistently function like third-party finished-product assays. Examples include ingredient-addition verification, capsule weight/disintegration checks, supplier batch documents, and some contaminant or microbiology panels. This does not erase the public-COA positive, but it limits how much manufacturing/testing rigor can be inferred from the COA links alone. 17, 18, 20, 22, 23 Exceptional · Industry Context / COA Depth Calibration |
| — | Not scored No verifiable NSF, USP, ISO 17025, or facility certificate numbers were found in public pages reviewed. COA coverage appears broad, but a comprehensive audit of all 400+ products and every batch was not possible from public search alone. |
| Formulation baseline 50 → 67 Mixed |
| +10 | Effective doses in majority of sampled products 10, 11, 12, 13, 14, 15, 17, 34, 35, 36, 37, 38 Current product pages and current clinical context; full weight. Pattern calculation: 6 of 7 sampled core formulas appeared reasonably dosed against common benchmarks or product-specific ingredient norms: Berberine 1,000 mg/day; Super Omega 3 810 mg EPA+DHA/day; Magnesium Threonate 2,000 mg Magtein/day; Super Curcuma 1,000 mg Meriva/day; L. gasseri formulas at 12B CFU/day; Daily 3 broad-dose multivitamin. 6/7 = 86%, but sample is limited, so awarded low end of +10 to +15. · full weight |
| +9 | Bioavailability technologies and delivery forms 12, 13, 14, 15, 16, 17, 35 Current sampled products; full weight. Rubric range +8 to +12. Awarded +9 for Meriva curcumin phytosome, Magtein magnesium L-threonate, triglyceride-form omega-3, liposomal vitamin C, gastro-resistant probiotics, and related delivery choices, while avoiding high-end credit because not all products use advanced delivery. · full weight |
| +7 | Branded / premium ingredients in sampled products 10, 12, 13, 15, 18, 21, 23, 35 Current sampled products; full weight. Rubric range +5 to +8. Awarded +7 because sampled formulas include branded or documented ingredients such as Meriva, Magtein, BioPQQ, Quatrefolic, Crominex 3+, SlimBiotics, Hobamine, Zooca/Calanus oil, and L. gasseri documentation. · full weight |
| +5 | Full label disclosure / no broad proprietary blend pattern in sampled supplement-facts panels 10, 11, 12, 13, 14, 15, 16 Current sampled product pages; full weight. Rubric range +5 to +7 for no proprietary blends. Awarded +5 because sampled supplement-facts panels generally disclose active amounts, but one non-core spray COA uses a proprietary excipient/hormone blend and a full-line audit was not performed. · full weight |
| +3 | Minimal fillers in sampled capsule products 11, 12, 13, 15, 16, 18 Current sampled products; full weight. Rubric range +3 to +5. Awarded low end because several sampled products use short excipient lists such as acacia gum, hypromellose, rice flour, or tocopherols, but some include additional standard processing aids such as calcium carbonate, fatty acids, or tricalcium phosphate. · full weight |
| −12 | Claims without adequate regulatory support 7 FDA warning letter dated January 21, 2026, inside last 2 years; 100% recency weight applied. Rubric range -8 to -12 for claims without evidence. FDA cited disease-treatment/prevention claims across 11 named products; awarded maximum in this range because the claim pattern was broad enough to trigger a formal FDA warning. · full weight |
| −5 | ConsumerLab reported that SuperSmart Mucuna Pruriens 15% L-Dopa contained an average of 148% of claimed L-dopa and that the suggested 5-capsule serving provided about 445 mg/day L-dopa, approximately 48% higher than a typical prescription levodopa starting dose, without carbidopa. This is not an underdosing issue; it is a potency overshoot and safety-relevance issue for a pharmacologically active botanical. 24 Exceptional · Potency / Label-Accuracy Concern |
| — | Not scored No comprehensive finished-product clinical trial portfolio was found. Dosing review sampled representative high-visibility products, not all 400+ items. |
| Transparency baseline 50 → 73 Adequate |
| +22 | Public COA access 3, 10, 11, 12, 13, 14, 15, 17, 18, 19, 20, 21, 22, 23 Current public product pages and sampled recent COAs; full weight. Rubric range +20 to +25. Awarded +22 because COA links are prominently available across sampled product pages, but not all sampled COAs are equally comprehensive or clearly independent finished-product assays. · full weight |
| +8 | Ownership and legal-entity disclosure 4, 5, 6 Current legal notices and 2026 Florida corporate filing; full weight. Rubric range +8 to +12. Awarded +8 because SuperSmart USA LLC and SuperSmart SA are disclosed, with Florida registry officers Benjamin Serra and Alexandre Serra listed, but deeper parent/shareholder ownership is not fully explained on product pages. · full weight |
| +5 | Manufacturing geography disclosed 2, 4, 5 Current FAQ/legal pages; full weight. Rubric range +6 to +10 for manufacturing-location disclosure. Awarded slightly below the rubric’s low end because SuperSmart gives broad U.S./Europe manufacturing geography and corporate/logistics addresses, but not specific manufacturing facility names and addresses for each product. · full weight |
| +4 | Facility certification claims shared 1, 2 Current brand pages; full weight. Rubric range +6 to +10 for sharing facility certifications. Awarded below range because SuperSmart claims GMP/HACCP manufacturing, but public pages reviewed did not provide certificate numbers, certifying bodies, or facility-specific verification. · full weight |
| +4 | Clear active-ingredient labeling on sampled products 10, 11, 12, 13, 14, 15, 16 Current sampled product pages; full weight. Rubric range +3 to +5. Awarded +4 because active amounts are generally visible on product pages, though a full-line audit was not performed. · full weight |
| +6 | Clear Subscribe & Save terms and no obvious hidden subscription trap 28 Current terms; full weight. Rubric range +3 to +5 for no hidden subscription terms or +8 to +12 for good subscription value. Awarded +6 in transparency because terms state account management, reminders, skip/cancel options, price-change notice, and no hidden-fee pattern was found. · full weight |
| −15 | Regulatory claim transparency failure / claims could not be legally supported as supplement claims 7 FDA warning letter dated January 21, 2026, inside last 2 years; 100% recency weight applied. Rubric range -10 to -15 for claims that cannot be verified. Awarded -15 because FDA determined multiple product claims established intended disease uses and cited unapproved new drug / misbranding issues. · full weight |
| −5 | Certification verification gap 1, 2, 30, 31 Current public-search gap; full weight. Rubric range -8 to -12 for unverifiable certification claims, but reduced to -5 because the brand primarily claims GMP/HACCP and FDA-registered laboratories, not NSF/USP marks, and absence of public cert numbers is common in the industry. · full weight |
| −6 | SuperSmart’s COA access is unusually good, but sampled COAs do not consistently disclose the same verification depth. Some show contaminant/microbiology panels or supplier assay data, while others emphasize capsule weights, disintegration, ingredient-addition verification, or batch composition without a finished-product potency assay. 17, 18, 20, 22, 23 Exceptional · COA Substance Gap |
| — | Not scored Could not verify facility-level GMP/HACCP certificate numbers or a product-by-product manufacturing location map. COA links were sampled, not exhaustively audited across the full catalog. |
| Safety baseline 90 → 42 Poor |
| −30 | FDA warning letter for unapproved new drug / misbranding issues 7 January 21, 2026 FDA warning letter; inside last 2 years, so 100% recency weight. Rubric range -25 to -35. Awarded -30 because FDA cited significant violations across 11 products and warned that failure to address them could result in legal action, while no recall, contamination, or consumer-harm finding was cited in the letter. · full weight |
| −8 | California Proposition 65 60-day notice alleging lead-warning violations 8, 9 Notice filed January 15, 2026; inside last 2 years, so 100% recency weight. Safety issues score even if isolated. Rubric analog: contamination/undisclosed chemical-warning concern. Awarded -8 because this is an allegation/notice concerning two products and warning adequacy, not a final judgment, settlement, mandatory recall, or FDA-confirmed contamination event. · full weight |
| −10 | ConsumerLab-reported L-dopa potency overage in SuperSmart Mucuna Pruriens 15% L-Dopa 24 ConsumerLab page surfaced in 2025/2026 search results; treated as inside last 2 years, full weight. Rubric analog: mislabeling / ingredient amount error -10 to -15. Awarded -10 because it is one tested product, but the reported 148% of claimed L-dopa and 445 mg/day suggested serving are safety-relevant for a pharmacologically active compound. · full weight |
| — | Not scored No complete FDA inspection-history file, Form 483 file, adverse-event report analysis, or full litigation docket review was available from public search. Prop 65 outcome was not found in the sources reviewed. |
| Value baseline 50 → 60 Mixed |
| +8 | Transparent pricing / no hidden-fee pattern found 10, 11, 12, 13, 14, 15, 28 Current product pages and subscription terms; full weight. Rubric range +6 to +10. Awarded +8 because one-time prices, subscription prices, delivery cadence, reminders, price-change notice, and cancellation controls are disclosed. · full weight |
| +8 | Subscription value 10, 13, 15, 28 Current Subscribe & Save terms and product pages; full weight. Rubric range +8 to +12. Awarded +8 because 15-20% displayed savings and account-based skip/cancel controls are useful, but terms also allow SuperSmart to adjust benefits/pricing and terminate subscriptions under stated conditions. · full weight |
| +8 | Premium partly justified by formulation quality, COA access, and branded ingredients 3, 10, 12, 13, 14, 15, 17, 18, 21, 35 Current sampled product pages and COAs; full weight. Rubric range +12 to +18 for premium justified by quality/certs. Awarded below range because public COAs and branded ingredients justify some premium, but the brand lacks NSF/USP verification and has recent regulatory concerns. · full weight |
| −14 | Premium / high pricing in sampled specialty and commodity products 11, 12, 13, 14, 15, 33 Current 2026 product pages and comparator result; full weight. Rubric range -12 to -18 for 20-50% above market. Pattern calculation: among sampled products, Berberine was $31 for 60 x 500 mg caps versus a Source Naturals comparator at $16.99 for 60 x 500 mg caps, while Magnesium Threonate and Super Curcuma sit in premium territory; Super Omega 3 and probiotics look more reasonable. Approximate pattern 3 of 6 sampled items premium/high = 50%, so mid-range -14, offset separately by formulation/COA positives. · full weight |
| — | Not scored Only a limited price-comparison sample was performed. A full value audit would compare at least 20 matched products against equivalent dose, form, certification, and serving count. |
| Sentiment baseline 60 → 87 Strong |
| +14 | Strong Trustpilot ratings and review volume 25, 26, 27 Current Trustpilot pages crawled June 2026; full weight. Rubric range +10 to +15 for 4.5+ stars and 200+ reviews. Awarded +14 because global profile shows 4.5/5 with 18,877 reviews and U.S. profile shows about 4.5/5 with 1,050 reviews, with a large recent review base. · full weight |
| +8 | Responsive to negative reviews / complaints 25, 26 Current Trustpilot data and 2026 review examples; full weight. Rubric range +6 to +10 for responsiveness. Awarded +8 because Trustpilot reports replies to 95% of negative reviews, typically within 24 hours, and a U.S. non-delivery complaint received a refund reply. · full weight |
| +5 | Practitioner / expert endorsements visible on brand site 3, 39 Current brand pages; full weight. Rubric analog +8 to +12 for community/practitioner endorsement but discounted because endorsements are hosted by the brand and not independently quantified. · full weight |
| — | Not scored No full BBB profile with substantive complaint history was found in the accessible search results. Social-media sentiment on Instagram/YouTube/TikTok/Facebook was not comprehensively quantified. |